D007166Chemicals & DrugsD27.505.696.477.6562179770.66626Immunosuppressive Agentsplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson9.070940.00172801217research area of0.9487910.00524511880subject area for33743151Reder AT, Centonze D, Naylor ML, Nagpal A, Rajbhandari R, Altincatal A, Kim M, Berdofe A, Radhakrishnan M, Jung E, Sandrock AW, Smirnakis K, Popescu C, de Moor CCNS drugsCOVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS Drugs. 2021 03; 35(3):317-330.CNS Drugs2021-03-20T00:00:002021COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.33859104El Ouali S, Rubin DT, Cohen BL, Regueiro MD, Rieder FCurrent opinion in gastroenterologyOptimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic. Curr Opin Gastroenterol. 2021 07 01; 37(4):313-319.Curr Opin Gastroenterol2021-07-01T00:00:002021Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.33951350Buisson A, Nancey S, Manlay L, Rubin DT, Hebuterne X, Pariente B, Fumery M, Laharie D, Roblin X, Bommelaer G, Pereira B, Peyrin-Biroulet L, Vuitton L, USTEK Post-Op study groupUnited European gastroenterology journalUstekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United European Gastroenterol J. 2021 06; 9(5):552-560.United European Gastroenterol J2021-05-05T00:00:002021Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.34409568Horton DB, Reder ATNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsMedications for Multiple Sclerosis and Risk of Malignancy: What Next? Neurotherapeutics. 2021 07; 18(3):1650-1653.Neurotherapeutics2021-08-18T00:00:002021Medications for Multiple Sclerosis and Risk of Malignancy: What Next?http://www.researchgate.net/profile/John_Fung2/stats/Research Gatehttps://rubinlab.uchicago.edu/Rubin Lab Sitehttps://publons.com/author/1183306/john-fung#profilePublonshttps://www.healthtap.com/#experts/11185863/aboutHealth Taphttps://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-diseaseInflammatory Bowel Disease Centerhttps://orcid.org/0000-0002-3038-0441ORCIDIBDMD37454520Gubic Š, Montalbano A, Sala C, Becchetti A, Hendrickx LA, Van Theemsche KM, Pinheiro-Junior EL, Altadonna GC, Peigneur S, Ilaš J, Labro AJ, Pardo LA, Tytgat J, Tomašic T, Arcangeli A, Peterlin Mašic LEuropean journal of medicinal chemistryImmunosuppressive effects of new thiophene-based KV1.3 inhibitors. Eur J Med Chem. 2023 Nov 05; 259:115561.Eur J Med Chem2023-06-25T00:00:002023Immunosuppressive effects of new thiophene-based KV1.3 inhibitors.MedicineSurgeryUniversity of ChicagoSangeetaBhoradeSangeeta Bhorade41.78927490000000-87.601250000000001846Bhorade, SangeetaASSOCIATE PROFESSORDavid T.RubinDavid T. Rubin41.78927490000000-87.60125000000000256Rubin, David T.ProfessorAnita S.Chong1mFhBK8SOfnamXNnYUHhvWD+6g==Anita S. Chong41.78927490000000-87.60125000000000535Chong, Anita S.ProfessorStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/Emeritatrue1ProfessorProfessortrue1Emeritus/EmeritaEmeritus/Emeritatrue1ASSOCIATE PROFESSORASSOCIATE PROFESSORtrue1ProfessorProfessortrue1ProfessorProfessorSurgery-TransplantJohnFungJohn Fung0.000000000000000.000000000000003383Fung, JohnProfessor